Incidence and Clinical Features of Immune-Related Acute Kidney Injury in Patients Receiving Programmed Cell Death Ligand-1 Inhibitors

BACKGROUND: Programmed cell death receptor ligand 1 (PD-L1) inhibitors are immune checkpoint inhibitors (ICIs) with a side effect profile that may differ from other classes of ICIs such as those directed against cytotoxic T-lymphocyte−associated protein 4 (CTLA-4) and programmed cell death 1 recepto...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Kidney Int Rep
المؤلفون الرئيسيون: Seethapathy, Harish, Zhao, Sophia, Strohbehn, Ian A., Lee, Meghan, Chute, Donald F., Bates, Halla, Molina, Gabriel E., Zubiri, Leyre, Gupta, Shruti, Motwani, Shveta, Leaf, David E., Sullivan, Ryan J., Rahma, Osama, Blumenthal, Kimberly G., Villani, Alexandra-Chloe, Reynolds, Kerry L., Sise, Meghan E.
التنسيق: Artigo
اللغة:Inglês
منشور في: Elsevier 2020
الموضوعات:
Clinical Research
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC7569697/
https://ncbi.nlm.nih.gov/pubmed/33102962
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2020.07.011
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة